Treating psoriatic arthritis: how effective are TNF antagonists? (Q33708854)

28 July 2017

8 references

31 July 2019

1 August 2019

20 November 2019

27 November 2019

13 December 2019

15 December 2019

1 February 2021

28 October 2022

Treating psoriatic arthritis: how effective are TNF antagonists? (English)

1 reference

28 July 2017

main subject

cell surface receptor

1 reference

31 July 2019

tumor necrosis factor

2 references

1 August 2019

1 February 2021

1 reference

20 November 2019

1 reference

27 November 2019

1 reference

13 December 2019

1 reference

15 December 2019

1 reference

Alice B Gottlieb

1

1 reference

28 July 2017

Christian E Antoni

series ordinal

2

1 reference

28 July 2017

publication date

21 June 2004

9 references

Arthritis Research and Therapy

28 July 2017

31 July 2019

1 August 2019

20 November 2019

27 November 2019

13 December 2019

15 December 2019

1 February 2021

28 October 2022

9 references

28 July 2017

31 July 2019

1 August 2019

20 November 2019

27 November 2019

13 December 2019

15 December 2019

1 February 2021

28 October 2022

6 Suppl 2

1 reference

28 July 2017

page(s)

S31-5

1 reference

Alefacept treatment in psoriatic arthritis: reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833458

Immunomodulating drugs in the management of psoriatic arthritis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833458

The immunologic basis for the treatment of psoriasis with new biologic agents

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833458

Psoriasis vulgaris--a sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833458

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833458

Current consensus and update on psoriasis therapy: a perspective from the U.S.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833458

Psoriatic arthritis. Genetics and HLA antigens

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833458

Does injectable gold retard radiologic evidence of joint damage in psoriatic arthritis?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833458

The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Multivariate relative risk model

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833458

The direct cost of care for psoriasis and psoriatic arthritis in the United States

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833458

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833458

A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833458

Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833458

Longterm methotrexate therapy in psoriatic arthritis: clinical and radiological outcome.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833458

Predominance of CD8+ T lymphocytes in psoriatic arthritis

30 October 2018

1 reference

12 December 2020

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

12 December 2020

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

12 December 2020

Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists

1 reference

12 December 2020

Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation

1 reference

12 December 2020

Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab

1 reference

12 December 2020

Photochemotherapy and psoriatic arthritis. A prospective study

1 reference

12 December 2020

HLA antigens in psoriatic arthritis

1 reference

12 December 2020

Psoriatic arthritis (PSA)--an analysis of 220 patients

1 reference

12 December 2020

Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease

1 reference

12 December 2020

Anti-inflammatory efficacy of low-dose cyclosporin A in psoriatic arthritis. A prospective multicentre study

1 reference

12 December 2020

Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid

1 reference

12 December 2020

Patterns of cytokine production in psoriatic synovium

1 reference

12 December 2020

1 reference

12 December 2020

The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991

1 reference

12 December 2020

Identifiers

DOI

10.1186/AR1016

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference